Potential Renoprotective Agents through Inhibiting CTGFCCN2 in Diabetic Nephropathy
Joint Authors
Miao, Lining
Cui, Wenpeng
Wang, Songyan
Li, Bing
Li, Chunguang
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-09-02
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD).
The development and progression of DN might involve multiple factors.
Connective tissue growth factor (CCN2, originally known as CTGF) is the one which plays a pivotal role.
Therefore, increasing attention is being paid to CCN2 as a potential therapeutic target for DN.
Up to date, there are also many drugs or agents which have been shown for their protective effects against DN via different mechanisms.
In this review, we only focus on the potential renoprotective therapeutic agents which can specifically abolish CCN2 expression or nonspecifically inhibit CCN2 expression for retarding the development and progression of DN.
American Psychological Association (APA)
Wang, Songyan& Li, Bing& Li, Chunguang& Cui, Wenpeng& Miao, Lining. 2015. Potential Renoprotective Agents through Inhibiting CTGFCCN2 in Diabetic Nephropathy. Journal of Diabetes Research،Vol. 2015, no. 2015, pp.1-11.
https://search.emarefa.net/detail/BIM-1068040
Modern Language Association (MLA)
Wang, Songyan…[et al.]. Potential Renoprotective Agents through Inhibiting CTGFCCN2 in Diabetic Nephropathy. Journal of Diabetes Research No. 2015 (2015), pp.1-11.
https://search.emarefa.net/detail/BIM-1068040
American Medical Association (AMA)
Wang, Songyan& Li, Bing& Li, Chunguang& Cui, Wenpeng& Miao, Lining. Potential Renoprotective Agents through Inhibiting CTGFCCN2 in Diabetic Nephropathy. Journal of Diabetes Research. 2015. Vol. 2015, no. 2015, pp.1-11.
https://search.emarefa.net/detail/BIM-1068040
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1068040
